CGEN (Compugen Ltd.) Stock Financials & Earnings | Market Cap Arena

CGEN (Compugen Ltd.) Stock Financials & Earnings | Market Cap Arena

CGENCompugen Ltd.

Mkt Cap$202M

Healthcare·Biotechnology·🇮🇱 Israel·NASDAQ

Revenue (TTM)$73M

Net Income (TTM)$35M

EPS (TTM)$0.37

Free Cash Flow (TTM)$31M

Gross Margin87.3%

Op. Margin43.1%

Net Margin48.6%

FCF Margin43.1%

P/S Ratio (TTM)2.8x

P/E Ratio (TTM)5.7x

YoY Rev Growth+161.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$10M
Q2 23	$0	$0	-$10M
Q3 23	$0	$0	-$11M
Q4 23	$33M	$31M	$18M
Q1 24	$3M	$457K	-$8M
Q2 24	$7M	$5M	-$3M
Q3 24	$17M	$14M	$4M
Q4 24	$1M	$796K	-$7M
Q1 25	$2M	-$116K	-$8M
Q2 25	$1M	-$408K	-$8M
Q3 25	$2M	$241K	-$8M
Q4 25	$67M	$64M	$56M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	26.9x	—
Q2 23	26.9x	—
Q3 23	26.9x	—
Q4 23	6.0x	—
Q1 24	5.6x	—
Q2 24	4.7x	—
Q3 24	3.4x	126.4x
Q4 24	7.3x	—
Q1 25	7.3x	—
Q2 25	9.1x	—
Q3 25	29.3x	—
Q4 25	2.8x	5.7x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 20	$0	$0
Q4 20	-$17M	-$17M
Q4 21	-$11M	-$11M
Q3 22	$0	$0
Q4 22	-$23M	-$23M
Q1 23	$0	$0
Q2 23	$0	$0
Q3 23	$0	$0
Q1 25	$0	$0
Q2 25	$0	$0
Q3 25	$0	$0
Q4 25	$32M	$31M

Capital Expenditures

CapEx

Quarter	CapEx
Q3 20	$0
Q4 20	$40K
Q4 21	$166K
Q3 22	$0
Q4 22	$351K
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0
Q4 25	$306K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+1.4%
Q2 23	—	+6.0%
Q3 23	—	-13.0%
Q4 23	+346.1%	+40.3%
Q1 24	—	+9.0%
Q2 24	—	-1.0%
Q3 24	—	+18.9%
Q4 24	-95.6%	-42.1%
Q1 25	-10.7%	-3.4%
Q2 25	-81.2%	-4.2%
Q3 25	-89.0%	-22.6%
Q4 25	+4477.3%	+26.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 20	$0	—
Q4 20	$3M	138.6%
Q4 21	$4M	—
Q3 22	$0	—
Q4 22	$4M	57.7%
Q1 23	$0	—
Q2 23	$0	—
Q3 23	$0	—
Q1 25	$0	0.0%
Q2 25	$0	0.0%
Q3 25	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$7M	$3M	$116K	—
Q2 23	$8M	$2M	$49K	—
Q3 23	$8M	$2M	$18K	—
Q4 23	$11M	$2M	$61K	—
Q1 24	$6M	$2M	$91K	—
Q2 24	$6M	$2M	$157K	—
Q3 24	$6M	$3M	$161K	—
Q4 24	$6M	$2M	$167K	—
Q1 25	$6M	$2M	$139K	—
Q2 25	$6M	$2M	$141K	—
Q3 25	$6M	—	—	$2M
Q4 25	$6M	—	—	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$74M	$0	$74M
Q2 23	$17M	$49M	$66M
Q3 23	$48M	$10M	$58M
Q4 23	$14M	$37M	$51M
Q1 24	$69M	$32M	$101M
Q2 24	$12M	$80M	$92M
Q3 24	$7M	$105M	$113M
Q4 24	$18M	$85M	$103M
Q1 25	$15M	$89M	$104M
Q2 25	$6M	$87M	$94M
Q3 25	$7M	$79M	$86M
Q4 25	$91M	$55M	$146M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	87M	+0.0%
Q2 23	87M	+0.6%
Q3 23	88M	+1.3%
Q4 23	88M	+0.1%
Q1 24	90M	+1.2%
Q2 24	90M	+0.0%
Q3 24	90M	+0.3%
Q4 24	90M	-0.3%
Q1 25	92M	+3.1%
Q2 25	94M	+1.3%
Q3 25	94M	+0.0%
Q4 25	95M	+1.3%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$2M	5
FY 15	$2M	5
FY 16	$142K	5
FY 17	$0	5
FY 18	$509K	35
FY 19	$0	5
FY 20	$400K	5
FY 21	$1M	5
FY 22	$2M	5
FY 23	$7M	5
FY 24	$6M	5
FY 25	$15M	5